Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2775 of 3546 entries
View as:

An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00057213 Org: User:
Start: 03/31/03 End: 04/30/07 Due: 04/30/08

Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02742766 Org: User:
Start: 03/14/16 End: 06/16/17 Due: 06/16/18

A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD

Phase: N/A Priority: Normal
NCT ID: NCT01313650 Org: User:
Start: 03/01/11 End: 04/05/12 Due: 04/05/13

Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01702480 Org: User:
Start: 11/05/12 End: 07/03/15 Due: 07/03/16

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Phase: N/A Priority: Normal
NCT ID: NCT00526669 Org: User:
Start: 03/31/08 End: 01/31/15 Due: 01/31/16

Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants

Phase: N/A Priority: Normal
NCT ID: NCT00697125 Org: User:
Start: 06/30/93 End: 07/31/94 Due: 07/31/95

Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs

Phase: N/A Priority: Normal
NCT ID: NCT01098500 Org: User:
Start: 02/28/09 End: 10/31/10 Due: 10/31/11

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

Phase: N/A Priority: Normal
NCT ID: NCT06527872 Org: User:
Start: 10/04/24 End: 03/29/29 Due: 03/29/30

Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib

Phase: N/A Priority: Normal
NCT ID: NCT00332566 Org: User:
Start: 06/30/06 End: 10/31/06 Due: 10/31/07

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03693612 Org: User:
Start: 11/26/18 End: 09/16/21 Due: 09/16/22

A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01943851 Org: User:
Start: 05/14/14 End: 04/30/20 Due: 04/30/21

Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01571999 Org: User:
Start: 03/29/12 End: 06/22/12 Due: 06/22/13

Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)

Phase: N/A Priority: Normal
NCT ID: NCT00256854 Org: User:
Start: 11/14/05 End: 09/21/06 Due: 09/21/07

Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00370318 Org: User:
Start: 09/30/06 End: 04/30/07 Due: 04/30/08

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT06702449 Org: User:
Start: 11/19/24 End: 09/02/27 Due: 09/02/28

Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Phase: N/A Priority: Normal
NCT ID: NCT02422264 Org: User:
Start: 01/22/16 End: 03/07/18 Due: 03/07/19

A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

Phase: N/A Priority: Normal
NCT ID: NCT06614725 Org: User:
Start: 10/01/24 End: 10/28/25 Due: 10/28/26

WEUSKOP5723: Prostate Cancer Study

Phase: N/A Priority: Normal
NCT ID: NCT01767363 Org: User:
Start: 11/30/12 End: 03/31/16 Due: 03/31/17

A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills

Phase: N/A Priority: Normal
NCT ID: NCT00508911 Org: User:
Start: 06/08/07 End: 10/22/07 Due: 10/22/08

Qualitative Analysis of Subject Experience of Nasal Polyps

Phase: N/A Priority: Normal
NCT ID: NCT03221192 Org: User:
Start: 07/31/17 End: 02/28/18 Due: 02/28/19

EU PV for Retapamulin-Prescribing

Phase: N/A Priority: Normal
NCT ID: NCT01153828 Org: User:
Start: 11/30/08 End: 08/31/12 Due: 08/31/13

A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03380429 Org: User:
Start: 01/31/18 End: 01/24/19 Due: 01/24/20

Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00265148 Org: User:
Start: 05/18/04 End: 07/10/08 Due: 07/10/09

Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00268203 Org: User:
Start: 09/30/98 End: 02/28/13 Due: 02/28/14

GSK706769 Repeat Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT00711386 Org: User:
Start: 05/16/08 End: 09/12/08 Due: 09/12/09